Experimental Medicine

JR building

Experimental Medicine is part of the Nuffield Department of Clinical Medicine, University of Oxford. Staff are based at the John Radcliffe Hospital, the Churchill Hospital, the Peter Medawar Building for Pathogen Research and the Weatherall Institute of Molecular Medicine.

Administration support for Experimental Medicine is based on Level 5 of the John Radcliffe Hospital in Headington with research units having their own admin support attached to where they are based.

 

Event

 
 
 
 
 
 
 

Oxford Dementia Research Day

Posted 16/06/2017

You can now register for the annual Oxford Research day jointly organised by NIHR Oxford Health Biomedical Research Centre and ARUK Oxford Local Network. This day celebrates the research in the region, including updates on research initiatives. 
12th July at St Anne's College.

European researchers' night

Posted 11/11/2016

The University of Oxford will be running its first ever European Researchers’ Night.
29 September 2017.

View events

Latest News

Mortality risks associated with emergency admissions during weekends and public holidays

Mortality risks associated with emergency admissions during weekends and public holidays

Posted 21/06/2017

An analysis of antibiotic use at the John Radcliffe hospital has shown that some Doctors use up to 30% less antibiotics without risk to patients. However they may admit more patients when the diagnosis is unclear - a ‘hold and observe’ strategy as opposed to ‘prescribe antibiotics and discharge’.

World Asthma Day Research Update

World Asthma Day Research Update

Posted 03/05/2017

Asthma is a chronic disease of the airways that is on the increase. 5.4 million people receive asthma medications in the UK each year. That is 1:12 adults and 1:11 children. Asthma is treatable and it is frustrating that despite the amount of treatment prescribed, one patient with asthma has an attack every ten seconds, and approximately 17% of asthma patients find it a disease difficult to ...

New potential treatment target for inflammatory bowel disease patients

New potential treatment target for inflammatory bowel disease patients

Posted 05/04/2017

Oxford Researchers have identified a potential therapeutic target for inflammatory bowel diseases. The findings are of particular importance to the 40% of patients who don’t respond to anti-TNF therapy, the current treatment option available. Professor Simon Travis co-led this study.

News archive

Podcast: Meet our Researchers

Derrick-Crook-thumb

TRACKING INFECTIONS

Understanding how an infection spreads is vitally important for prevention. Whole genome sequencing of microorganisms allows us to construct family trees of infections, from donnor to recipients, and understand how microbes behave in general. Through its genetic code, we can also predict whether a germ is susceptible or resistant to a specific antibiotic, and give patients a more stratified and personalised treatment, as explained by Professor Derrick Crook.

View podcast

Mentoring

The Nuffield Department of Medicine operates unit-based formal mentoring schemes for all externally funded research fellows.

Read More

Graduate Studies

We currently have a large number of postgraduate students studying within Experimental Medicine.

Read More

 

Jobs and Vacancies

There is a wide range of opportunities in the Experimental Medicine Division.

Read more